Caricamento...
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson’s disease
The LRRK2 (leucine-rich repeat protein kinase-2) is mutated in a significant number of Parkinson’s disease patients, but little is known about its regulation and function. A common mutation changing Gly(2019) to serine enhances catalytic activity, suggesting that small-molecule inhibitors might have...
Salvato in:
| Autori principali: | , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2009
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3759966/ https://ncbi.nlm.nih.gov/pubmed/19740074 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BJ20091035 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|